MY171947A - Method of preparing a muscadine pomace extract - Google Patents
Method of preparing a muscadine pomace extractInfo
- Publication number
- MY171947A MY171947A MYPI2015703087A MYPI2015703087A MY171947A MY 171947 A MY171947 A MY 171947A MY PI2015703087 A MYPI2015703087 A MY PI2015703087A MY PI2015703087 A MYPI2015703087 A MY PI2015703087A MY 171947 A MY171947 A MY 171947A
- Authority
- MY
- Malaysia
- Prior art keywords
- extracts
- anthocyanins
- grapes
- extract
- juice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
Abstract
Muscadine grape extracts are disclosed that have antioxidant properties. The extracts are a mixture of extracts from bronze and purple muscadine grapes that unexpectedly increase the solubility of ellagic acid in the mixture. Solvent extracts are obtained in some examples by water extracting the pomaces of the grapes from which the juice has substantially been removed. Further surprising increases in ellagic acid solubility can also be obtained by adding an additional source of anthocyanins to the extract, for example by including in the composition an extract of whole purple muscadine grapes from which substantial amounts of the juice have not been removed. Other additional sources of anthocyanins include blueberries, blackberries and raspberries; the additional source of anthocyanins can be obtained from a fruit processing waste stream to increase the efficiency of the production process.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/828,707 US9173916B2 (en) | 2008-07-31 | 2013-03-14 | Method of preparing a muscadine pomace extract |
Publications (1)
Publication Number | Publication Date |
---|---|
MY171947A true MY171947A (en) | 2019-11-08 |
Family
ID=51625227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2015703087A MY171947A (en) | 2013-03-14 | 2014-03-12 | Method of preparing a muscadine pomace extract |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP6445518B2 (en) |
KR (1) | KR20150131270A (en) |
CN (1) | CN105188419B (en) |
CA (1) | CA2904636C (en) |
HK (1) | HK1219209A1 (en) |
MX (1) | MX366664B (en) |
MY (1) | MY171947A (en) |
PH (1) | PH12015501949A1 (en) |
TW (1) | TWI621444B (en) |
WO (1) | WO2014159677A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7241483B2 (en) * | 2018-07-23 | 2023-03-17 | 株式会社ノエビア | skin composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3283553B2 (en) * | 1991-12-10 | 2002-05-20 | 株式会社創研 | Cosmetics |
US6190716B1 (en) * | 1999-02-17 | 2001-02-20 | Scott O. Galbreath, Jr. | Method for preparing a grape derived product |
JP5010077B2 (en) * | 2001-09-05 | 2012-08-29 | ライオン株式会社 | Ellagic acid dispersion and composition for external use |
US20040234671A1 (en) * | 2003-05-20 | 2004-11-25 | Ector Betty J. Houston | Method and system for processing muscadine grape pomace |
US20060024392A1 (en) * | 2004-04-20 | 2006-02-02 | The University Of Maryland | Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent |
NZ594596A (en) * | 2006-02-10 | 2011-10-28 | Mannatech Inc | All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
KR20100014799A (en) * | 2007-01-17 | 2010-02-11 | 엔베쎄 뉴트라쇠틱 비지니스 컨썰팅 | Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition |
EP2033526A1 (en) * | 2007-09-07 | 2009-03-11 | Probelte Pharma, S.A. | Nutritional products comprising pomegranate extracts containing ellagitannins and their use |
CA2732306C (en) * | 2008-07-31 | 2017-02-28 | Shaklee Corporation | Muscadine compositions with improved anti-oxidant activity |
US9173916B2 (en) * | 2008-07-31 | 2015-11-03 | Shaklee Corporation | Method of preparing a muscadine pomace extract |
TWI484918B (en) * | 2008-07-31 | 2015-05-21 | Shaklee Corp | Method of preparing a muscadine pomace extract |
WO2010014873A2 (en) * | 2008-07-31 | 2010-02-04 | Shaklee Corporation | Method of preparing a muscadine pomace extract |
WO2011155505A1 (en) * | 2010-06-09 | 2011-12-15 | 花王株式会社 | Manufacturing method for polyphenol composition |
-
2014
- 2014-03-12 CA CA2904636A patent/CA2904636C/en active Active
- 2014-03-12 MY MYPI2015703087A patent/MY171947A/en unknown
- 2014-03-12 KR KR1020157029287A patent/KR20150131270A/en not_active Application Discontinuation
- 2014-03-12 WO PCT/US2014/024717 patent/WO2014159677A1/en active Application Filing
- 2014-03-12 JP JP2016501617A patent/JP6445518B2/en active Active
- 2014-03-12 CN CN201480015151.2A patent/CN105188419B/en active Active
- 2014-03-12 MX MX2015012676A patent/MX366664B/en active IP Right Grant
- 2014-03-14 TW TW103109229A patent/TWI621444B/en active
-
2015
- 2015-09-03 PH PH12015501949A patent/PH12015501949A1/en unknown
-
2016
- 2016-06-22 HK HK16107264.6A patent/HK1219209A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201501721A (en) | 2015-01-16 |
JP2016518110A (en) | 2016-06-23 |
TWI621444B (en) | 2018-04-21 |
MX366664B (en) | 2019-07-18 |
PH12015501949A1 (en) | 2016-01-11 |
HK1219209A1 (en) | 2017-03-31 |
WO2014159677A1 (en) | 2014-10-02 |
MX2015012676A (en) | 2016-02-16 |
CA2904636C (en) | 2021-05-04 |
JP6445518B2 (en) | 2018-12-26 |
CN105188419B (en) | 2018-06-19 |
CN105188419A (en) | 2015-12-23 |
CA2904636A1 (en) | 2014-10-02 |
KR20150131270A (en) | 2015-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500093A1 (en) | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | |
EA201890883A1 (en) | VACUUM DISTILLATION FOR ENRICHING CANNABIDIOL | |
AU2015217822A8 (en) | Method for producing vitamin E-enriched, especially tocotrienol-enriched, compositions from natural oils | |
UA109652C2 (en) | METHODS OF EXTRACTION AND SEPARATION OF CELLULOSE MATERIAL COMPONENTS | |
MX2016002288A (en) | Oil extraction aids in grain processing. | |
PH12017502056A1 (en) | A biostimulant formulation for improving plant growth and uses thereof | |
MX341686B (en) | Composition containing scirpusin b, and process for producing composition containing scirpusin b. | |
MX2018002830A (en) | Process for the extraction of silica. | |
EP3484459A4 (en) | Decarboxylation of cannabidiolic acid in hemp biomass&hemp extract | |
GR1007894B (en) | Method for the production of meat-based products with oil addition | |
MD588Y (en) | Process for producing red wine | |
PH12015501949A1 (en) | Method for preparing a muscadine pomace extract | |
MX2015012841A (en) | Bioactive compositions from fruit and methods for their production. | |
MX2016001720A (en) | Surface-modified metal colloids and production thereof. | |
IN2015MU00580A (en) | ||
MX357455B (en) | Drying process by micro aspersion and preparation of the hesperidin/cyclodextrin inclusion complex. | |
RU2010124076A (en) | METHOD FOR PRODUCING CHAGA EXTRACTS | |
PH22015000588U1 (en) | PROCESS OF PRODUCING ANTHOCYANIN POWDER FROM PURPLE CORN (Zea mays var. Kculli) | |
RU2012152178A (en) | METHOD FOR PRODUCING ANTI-OXIDATIVE AND ANTI-INFLAMMATORY ACTIVITY PRODUCT | |
MD4360B1 (en) | Process for producing myxoxanthophyll from Spirulina platensis cyanobacterium biomass | |
GR1008312B (en) | Production of an alcoholic fig-based drink called souma | |
EA201501159A1 (en) | METHOD FOR OBTAINING A GRANULATED COMPOSITION AND A PRODUCT OBTAINED BY THIS METHOD | |
MD4576B1 (en) | Process for producing an anthocyanin concentrate from grapes | |
PL415207A1 (en) | Method for separating acrylic acid from the post-production sewage | |
Bowen | Antioxidative Effect of Alcoholic Extract from Chlorella |